All lobbying filings

BROWNSTEIN HYATT FARBER SCHRECK, LLP

BROWNSTEIN HYATT FARBER SCHRECK, LLP filed a Q3 report for CARDINAL HEALTH, INC. on October 16, 2026, reporting $60,000 in lobbying income.

Lobbying for CARDINAL HEALTH, INC. · Health care services company

All filings by BROWNSTEIN HYATT FARBER SCHRECK, LLP · Everything CARDINAL HEALTH, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 16, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Ohio

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

General issues affecting the health care industry such as drug pricing, pharmaceutical drugs, medical devices, workforce shortages, and product shortages.

Pharmacy

Pharmaceutical tariffs Supply chain issues affecting the pharmaceutical industry

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.